Teva Pharmaceutical Industries Ltd at Bank of America Healthcare Conference Transcript
(technical difficulty)
in your healthcare conference in Las Vegas. I'm pleased to be introducing our next company presenter, Teva Pharmaceuticals. We've got CEO, Richard Francis, and Eric Hughes, Head of Global R&D. My name is Jason Gerberry. I cover SMID-cap biotech and specialty pharma and so gentlemen, thanks for joining.
Questions & Answers
Richard, maybe I'll start with a high-level point. You came on board, you had a Capital Markets Day in May of last year, emphasizing sort of a Pivot to Growth, your predecessor put out a lot of fires, stabilize the base. Then you come in, now that things were -- the foundation was stabilized and you're looking to drive that Pivot to Growth, where do you see since, kind of, laying out that edict about a year ago, the company having progressed? Maybe you just want to highlight those key points and then we'll go from there.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
